Velan Capital Investment Management LP bought JSPR

February 8, 2024 · Form 4 insider transaction

Velan Capital Investment Management LP bought 350,000 shares of Jasper Therapeutics, Inc. at $12.95 per share, a transaction worth $4.53M. The trade was recorded as open-market purchase and disclosed on an SEC Form 4, filed 1 day after the transaction.

Direction
Acquired (buy-side)
Shares
350,000
Price
$12.95
Total value
$4.53M
Role
SecurityCommon Stock, par value $0.0001 per share
Transaction codeP: Open-market purchase
Transaction dateFebruary 8, 2024
Filing dateFebruary 9, 2024
Shares owned after1,188,500
OwnershipIndirect
10b5-1 planNo
AmendedNo

Footnotes

This Form 4 is filed jointly by Velan Capital Master Fund LP ("Velan Master"), Avego Healthcare Capital, L.P. ("Avego Fund"), Velan Capital Holdings LLC ("Velan GP"), Avego Healthcare Capital Holdings, LLC ("Avego GP"), Avego Management, LLC ("Avego Management"), Velan Capital Investment Management LP ("Velan Capital"), Velan Capital Management LLC ("Velan IM GP"), Balaji Venkataraman and Adam Morgan (collectively, the "Reporting Persons"). Each of the Reporting Persons may be deemed to be a member of a Section 13(d) group that no longer collectively beneficially owns more than 10% of the Issuer's outstanding shares. Each of the Reporting Persons disclaims beneficial ownership of the securities reported herein except to the extent of his or its pecuniary interest therein.; Reflects a 1-for-10 reverse stock split of the Issuer's common stock, effected on January 4, 2024.; Securities owned directly by Velan Master. As the general partner of Velan Master, Velan GP may be deemed to beneficially own the securities owned directly by Velan Master. As the investment manager of Velan Master, Velan Capital may be deemed to beneficially own the securities owned directly by Velan Master. As the general partner of Velan Capital, Velan IM GP may be deemed to beneficially own the securities owned directly by Velan Master. As the managing members of Velan GP and Velan IM GP, Messrs. Venkataraman and Morgan may be deemed to beneficially own the securities owned directly by Velan Master.

View the original Form 4 on SEC EDGAR